# FDA Inspection 1047939 - Carter BloodCare at Grand Prairie - March 29, 2018

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-grand-prairie/c18a4272-0be1-4e6e-9ec3-138ba7b3a80e
Source feed: FDA_Inspections

> FDA Inspection 1047939 for Carter BloodCare at Grand Prairie on March 29, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1047939
- Company Name: Carter BloodCare at Grand Prairie
- Inspection Date: 2018-03-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1169690 - 2022-05-11](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-grand-prairie/bf1ea46e-3d04-4609-aca0-7209987575a6)
- [FDA Inspection 1169690 - 2022-05-11](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-grand-prairie/27fff627-d51f-40b0-9842-7734ad8c4ba2)
- [FDA Inspection 963077 - 2016-03-11](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-grand-prairie/b0ed8f28-c27a-48f1-a38b-abb561b31c05)
- [FDA Inspection 866251 - 2014-02-13](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-grand-prairie/70786916-8fdc-40af-bf66-9dc9a0e2ace6)
- [FDA Inspection 798617 - 2012-09-13](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-grand-prairie/e272709b-ddd4-40f4-8b9e-6a44b107bbfb)

Company: https://www.keypedia.com/companies/carter-bloodcare-at-grand-prairie/ed9d64f2-4165-4562-9abf-15f78aa710f7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d